Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine Signaling Factors and Scaffold-Based Differentiation for Immunomodulation and Tissue Regeneration (N/A)
- Target
- N/A
- Molecular classification
- Cytokine, Growth Factor, Enzyme, Extracellular Vesicle, Neurotrophin, Scaffold (Biomaterial)
01
Overview
This target encompasses a broad spectrum approach leveraging the body's own reparative communication networks—primarily mediated by locally acting soluble/paracrinally delivered molecules—to achieve immunomodulation and multi-tissue regeneration. The combination with biomaterial scaffolds further enhances targeted delivery/effectiveness for applications ranging from orthopedics to organ protection/regeneration in preclinical models. Key components include TGFβ1, HGF, IL-10, IDO, extracellular vesicles (EVs), other cytokines and growth factors, neurotrophins, and scaffold-based differentiation mechanisms.
- Other names
- MSC-derived secretomeMesenchymal stem/stromal cell paracrine factorsRegenerative microenvironmentImmunomodulatory secretome
02
Mechanism of action
Multiple mechanisms, including immunosuppression via IL-10 and TGFβ1, tissue regeneration via HGF and other growth factors, neuroprotection via neurotrophins, and scaffold-guided cell differentiation.
03
Biological functions
ImmunomodulationAnti-inflammationTissue RepairTissue RegenerationNeuroprotectionCell ProliferationCell MigrationAngiogenesisCell Differentiation
04
Disease associations
InflammationFibrosisWound HealingIschemiaNeurodegenerative DiseasesAutoimmune DiseasesOrthopedic DisordersLiver DiseaseCardiovascular DiseaseMetabolic Disease
05
Safety considerations
Potential for off-target effects due to broad activity of paracrine factorsRisk of unwanted immune suppressionPotential for uncontrolled cell proliferation or differentiationScaffold biocompatibility and degradationVariability in MSC source and paracrine factor productionPotential for tumorigenesis
06
Biomarkers
Levels of TGFβ1Levels of HGFLevels of IL-10Levels of IDOEV content (e.g., miRNA profile)Markers of inflammation (e.g., TNF-α, IL-6)Markers of tissue regeneration (e.g., collagen synthesis)Markers of angiogenesis (e.g., VEGF)
Beyond the preview
Go deeper on Paracrine Signaling Factors and Scaffold-Based Differentiation for Immunomodulation and Tissue Regeneration (N/A).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Paracrine Signaling Factors and Scaffold-Based Differentiation for Immunomodulation and Tissue Regeneration (N/A).